View Our Webinar: Enabling Better Outcomes Through SMA Carrier Screening
With the availability of SMA gene therapies, carrier screening can lead to earlier treatment and better outcomes. Learn how you can make a difference by offering carrier screening to your patients.
Hear about one family’s journey with SMA and how the latest gene therapies can alter the course of SMA in infants as early as a few weeks after birth.
Alecia CampMother of Lola who was diagnosed with SMA at 5 months of age
Barry Byrne, MDPediatric cardiologist specializing in gene therapy at the University of Florida
Learn about SMA and the need for screening through Lola’s story
Father of Lola (born with SMA)
Learn More About Horizon
All carrier screening is not equal, and choosing the right test for your patients is critical. Traditional screening misses ~60% of patients Horizon identifies as at-risk SMA carriers. Learn how Horizon leverages advanced technology and unmatched support to help you and your patients.